chuckago

While stressing the FDA's recently redoubled efforts to ensure drug safety, Lester Crawford, acting head of the agency, argued that its role in protecting consumers had come at the cost of developing new therapies.

The strongly pro drug industry comments came in a written speech to the Economist pharmaceuticals conference in London prepared by Dr Crawford, and provide an insight into his priorities in the build-up to his imminent confirmation hearings.